Bishop Score.
Conditions
Interventions
Intervention 1: The drug used in this study is soft Barich EPO capsule or Evening Primrose Oil capsule produced by Barich Essence Company. Each soft capsule contains 1000 mg of Evening Primrose Oil
Sponsors
Rafsanjan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclination to participate in the study Tendency to normal delivery Selection of Niknafs hospital for delivery Mother’s age is 18-35 years Gestational age 38 weeks based on first trimester Ultrasonography or reliable IMP Single fetus with cephalic presentation The basis of the results of the last ultrasound Nulliparality the integrity of the embryonic membranes
Exclusion criteria
Exclusion criteria: Non-use of two successive capsules of Primrose Primrose capsule susceptibility Emergency intervention for maternal or embryonic reasons Unwillingness of the research unit to continue cooperation Vaginal bleeding Presence of contraindications for use of Evening Primrose capsule (diseases associated with disorders Hemorrhagic agents, anticoagulant drugs, Patients with history of psychiatric disorders in the phenothiazine category, and epilepsy patients) History of known chronic disease Pregnancy complications such as Hydromenosis, Oligohydroamenia, Pre-eclampsia, Eclampsia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bishop score. Timepoint: After intervention. Method of measurement: Physical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarzeyeh Loripoor
Faculty of Nursing and Midwifery
Outcome results
None listed